Literature DB >> 18662362

Diagnosis and treatment of neonatal diabetes: a United States experience.

Julie Støy1, Siri Atma W Greeley, Veronica P Paz, Honggang Ye, Ashley N Pastore, Kinga B Skowron, Rebecca B Lipton, Fran R Cogen, Graeme I Bell, Louis H Philipson.   

Abstract

BACKGROUND/
OBJECTIVE: Mutations in KCNJ11, ABCC8, or INS are the cause of permanent neonatal diabetes mellitus in about 50% of patients diagnosed with diabetes before 6 months of age and in a small fraction of those diagnosed between 6 and 12 months. The aim of this study was to identify the genetic cause of diabetes in 77 consecutive patients referred to the University of Chicago with diabetes diagnosed before 1 yr of age.
METHODS: We used Oragene DNA Self-Collection kit to obtain a saliva sample for DNA. We sequenced the protein-coding regions of KCNJ11, ABCC8, and INS using standard methods.
RESULTS: We enrolled 32 patients diagnosed with diabetes before 6 months of age and 45 patients diagnosed between 6 and 12 months. We identified a mutation in KCNJ11 in 14 patients from 12 families and in INS in 7 patients from 4 families. Three of the patients with an INS mutation were diagnosed with diabetes between 6 and 12 months of age. Finally, we found that two patients had an abnormality of chromosome 6q24 associated with transient neonatal diabetes mellitus.
CONCLUSIONS: We were able to establish a genetic cause of diabetes in 63% of patients diagnosed with diabetes before 6 months of age and in 7% of patients diagnosed between 6 and 12 months. Genetic testing, which is critical for guiding appropriate management, should be considered in patients diagnosed with diabetes before 1 yr of age, especially if they are autoantibody negative, although the presence of autoantibodies does not rule out a monogenic cause.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18662362      PMCID: PMC2574846          DOI: 10.1111/j.1399-5448.2008.00433.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  34 in total

1.  EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome.

Authors:  M Delépine; M Nicolino; T Barrett; M Golamaully; G M Lathrop; C Julier
Journal:  Nat Genet       Date:  2000-08       Impact factor: 38.330

Review 2.  Transient neonatal diabetes mellitus and macroglossia.

Authors:  M Battin; C Yong; M Phang; J Daaboul
Journal:  J Perinatol       Date:  1996 Jul-Aug       Impact factor: 2.521

3.  Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes.

Authors:  I K Temple; R J Gardner; D J Mackay; J C Barber; D O Robinson; J P Shield
Journal:  Diabetes       Date:  2000-08       Impact factor: 9.461

4.  An imprinted locus associated with transient neonatal diabetes mellitus.

Authors:  R J Gardner; D J Mackay; A J Mungall; C Polychronakos; R Siebert; J P Shield; I K Temple; D O Robinson
Journal:  Hum Mol Genet       Date:  2000-03-01       Impact factor: 6.150

5.  Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 Gene encoding the Kir6.2 subunit of the beta-cell potassium adenosine triphosphate channel.

Authors:  Anna L Gloyn; Elizabeth A Cummings; Emma L Edghill; Lorna W Harries; Rachel Scott; Teresa Costa; I Karen Temple; Andrew T Hattersley; Sian Ellard
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

6.  Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy.

Authors:  Jørn V Sagen; Helge Raeder; Eba Hathout; Naim Shehadeh; Kolbeinn Gudmundsson; Halvor Baevre; Dianne Abuelo; Chanika Phornphutkul; Janne Molnes; Graeme I Bell; Anna L Gloyn; Andrew T Hattersley; Anders Molven; Oddmund Søvik; Pål R Njølstad
Journal:  Diabetes       Date:  2004-10       Impact factor: 9.461

7.  Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.

Authors:  Anna L Gloyn; Ewan R Pearson; Jennifer F Antcliff; Peter Proks; G Jan Bruining; Annabelle S Slingerland; Neville Howard; Shubha Srinivasan; José M C L Silva; Janne Molnes; Emma L Edghill; Timothy M Frayling; I Karen Temple; Deborah Mackay; Julian P H Shield; Zdenek Sumnik; Adrian van Rhijn; Jerry K H Wales; Penelope Clark; Shaun Gorman; Javier Aisenberg; Sian Ellard; Pål R Njølstad; Frances M Ashcroft; Andrew T Hattersley
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

8.  Prevalence and HLA association of GAD65 antibodies in Hungarian schoolchildren.

Authors:  Robert Hermann; Gyula Soltész
Journal:  Hum Immunol       Date:  2003-01       Impact factor: 2.850

9.  Neonatal diabetes mellitus due to complete glucokinase deficiency.

Authors:  P R Njølstad; O Søvik; A Cuesta-Muñoz; L Bjørkhaug; O Massa; F Barbetti; D E Undlien; C Shiota; M A Magnuson; A Molven; F M Matschinsky; G I Bell
Journal:  N Engl J Med       Date:  2001-05-24       Impact factor: 91.245

10.  Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients.

Authors:  Martine Vaxillaire; Céline Populaire; Kanetee Busiah; Hélène Cavé; Anna L Gloyn; Andrew T Hattersley; Paul Czernichow; Philippe Froguel; Michel Polak
Journal:  Diabetes       Date:  2004-10       Impact factor: 9.461

View more
  40 in total

Review 1.  6q24 transient neonatal diabetes.

Authors:  I Karen Temple; Julian P H Shield
Journal:  Rev Endocr Metab Disord       Date:  2010-09       Impact factor: 6.514

2.  Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes.

Authors:  Brian W Thurber; David Carmody; Elizabeth C Tadie; Ashley N Pastore; Jazzmyne T Dickens; Kristen E Wroblewski; Rochelle N Naylor; Louis H Philipson; Siri Atma W Greeley
Journal:  Diabetologia       Date:  2015-04-17       Impact factor: 10.122

Review 3.  Outpatient Management of Pediatric Type 1 Diabetes.

Authors:  Joni K Beck; Fran R Cogen
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Sep-Oct

Review 4.  Neonatal diabetes mellitus: a model for personalized medicine.

Authors:  Siri Atma W Greeley; Susan E Tucker; Rochelle N Naylor; Graeme I Bell; Louis H Philipson
Journal:  Trends Endocrinol Metab       Date:  2010-04-29       Impact factor: 12.015

5.  Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.

Authors:  David B Sacks; Mark Arnold; George L Bakris; David E Bruns; Andrea Rita Horvath; M Sue Kirkman; Ake Lernmark; Boyd E Metzger; David M Nathan
Journal:  Diabetes Care       Date:  2011-06       Impact factor: 19.112

6.  Reevaluation of a case of type 1 diabetes mellitus diagnosed before 6 months of age.

Authors:  Angus G Jones; Andrew T Hattersley
Journal:  Nat Rev Endocrinol       Date:  2010-04-06       Impact factor: 43.330

7.  Permanent neonatal diabetes mellitus: prevalence and genetic diagnosis in the SEARCH for Diabetes in Youth Study.

Authors:  Roopa Kanakatti Shankar; Catherine Pihoker; Lawrence M Dolan; Debra Standiford; Angela Badaru; Dana Dabelea; Beatriz Rodriguez; Mary Helen Black; Giuseppina Imperatore; Andrew Hattersley; Sian Ellard; Lisa K Gilliam
Journal:  Pediatr Diabetes       Date:  2012-10-10       Impact factor: 4.866

Review 8.  Technologies for diabetes genomics.

Authors:  Patricia W Mueller
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

9.  Mutant INS-gene induced diabetes of youth: proinsulin cysteine residues impose dominant-negative inhibition on wild-type proinsulin transport.

Authors:  Ming Liu; Leena Haataja; Jordan Wright; Nalinda P Wickramasinghe; Qing-Xin Hua; Nelson F Phillips; Fabrizio Barbetti; Michael A Weiss; Peter Arvan
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

10.  Tooth discoloration in patients with neonatal diabetes after transfer onto glibenclamide: a previously unreported side effect.

Authors:  Janani Kumaraguru; Sarah E Flanagan; Siri Atma W Greeley; Roos Nuboer; Julie Støy; Louis H Philipson; Andrew T Hattersley; Oscar Rubio-Cabezas
Journal:  Diabetes Care       Date:  2009-05-12       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.